Wednesday, October 02, 2019 2:21:39 PM
MGIC is expected to end 2019 with a book value of $12.02 according to CREDIT SUISSE ANALYSTS. While NMIH is trading at 2.3 times it's book value. MTG PRICE EARNINGS RATIO IS 7.28 VS 14 for NMIH.
MGIC PAYS A 2% DIVIDEND. MGIC has the highest net operating income of 4 PMI PUREPLAY COMPANIES. They ended 2018 at $660 million NOI.
CASH FLOW/POSITION: 'As of June 30, 2019, we had approximately $333 million in cash and, investments at our holding company. These resources are maintained
primarily to service our debt interest expense."(FROM SEC 10Q JUNE 2019)
If, MGIC WAS TO maintain a cash cushion of available assets EQUAL to 20% in excess of requirements, they would have a book value of $13.26 per share. MTG current market is $12.49 per share.
"Capital Adequacy
PMIERs
As of June 30, 2019, MGIC’s Available Assets under PMIERs totaled
approximately $4.4 billion, an excess of approximately $1.1 billion over its
Minimum Required Assets; and MGIC is in compliance with the requirements of the PMIERs and eligible to insure loans delivered to or purchased by the GSEs."
Data from SEC 10Q JUNE 2019
Recent NMIH News
- NMI Holdings, Inc. Reports Record First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/30/2024 08:01:00 PM
- NMI Holdings, Inc. to Announce First Quarter 2024 Financial Results on April 30, 2024 • GlobeNewswire Inc. • 04/11/2024 08:05:00 PM
- National MI Announces Enhanced Integration With PMI Rate Pro • GlobeNewswire Inc. • 04/04/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 01:05:31 PM
- NMI Holdings, Inc. Announces CFO Transition • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:15:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 09:38:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:07:32 PM
- NMI Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/14/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 01:47:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 01:44:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 01:38:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 01:36:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 01:35:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/10/2024 01:46:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/10/2024 01:40:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/10/2024 01:38:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/10/2024 01:34:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/10/2024 01:28:41 AM
- NMI Holdings, Inc. Receives Ratings Upgrade from Moody’s Investors Service • GlobeNewswire Inc. • 01/31/2024 07:38:16 PM
- NMI Holdings, Inc. Receives “A-” Insurer Financial Strength and “BBB+” Senior Debt Ratings from Fitch • GlobeNewswire Inc. • 01/19/2024 01:00:00 PM
- NMI Holdings, Inc. to Announce Fourth Quarter 2023 Financial Results on February 14, 2024 • GlobeNewswire Inc. • 01/19/2024 11:00:00 AM
- NMI Holdings, Inc. Announces Upgraded S&P Financial Strength Rating to BBB+ • GlobeNewswire Inc. • 01/11/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:18:07 PM
- NMI Holdings, Inc. Elevates William Leatherberry to Chief Administrative Officer • GlobeNewswire Inc. • 12/04/2023 09:06:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM